No 10Y consistency score yet for revenue — the window needs more comparable quarters.
Valuation vs own 10Y history: P/S N/A · No P/S — trailing revenue unavailable or non-positive.
Chart series for revenue are being prepared.
No 10Y consistency score yet for revenue — the window needs more comparable quarters.
Valuation vs own 10Y history: P/S N/A · No P/S — trailing revenue unavailable or non-positive.
Chart series for revenue are being prepared.
The latest delayed quote for NewHold Investment Corp IV Class A Ordinary Shares (NHIV) stock was $10.10 as of Oct 6, 2026, 10:35 AM EDT, up 0.50% from the previous close.
NewHold Investment Corp. IV is a blank check company.
Financial - Conglomerates · New York, NY
Next Earnings Date
N/A
EPS Estimate
N/A
Revenue Est.
N/A
Last Quarter Results
EPS
N/A
vs Estimate
N/A
Revenue
N/A
vs Estimate
N/A
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR | Compare |
|---|---|---|---|---|---|---|---|
| 1NHIV | $277.49M | $10.10 | +0.50% | N/A | N/A | N/A | N/A |
| 2XSLL | $277.01M | $10.01 | +0.07% | N/A | N/A | N/A | vs NHIV |
| 3WNEB | $278.13M | $13.82 | -0.14% | +20.30% | +12.87% | +8.86% | vs NHIV |
| 4FBLA | $279.43M | $17.29 | +1.29% | +41.78% | N/A | N/A | vs NHIV |
| 5NKSH | $274.99M | $43.18 | +0.49% | +55.01% | +8.65% | +6.47% | vs NHIV |
| 6ISBA | $281.09M | $38.34 | +1.23% | +10.37% | +12.29% | +7.87% | vs NHIV |
forward FY estimate
N/A
Consensus Rating
No analyst recommendations available
Average Price Target
N/A
Low
N/A
Current
$10.10
High
N/A